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Spontaneous bacterial peritonitis in patients of
cirrhosis of liver with ascites
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Background: Spontaneous bacterial peritonitis (SBP) is a com-
mon and fatal complication occurring in cirrhotic patients with
ascites. It is deﬁned as infected ascites in the absence of any recog-
nisable secondary cause of infection. This study was undertaken
to ﬁnd out the rate of occurrence of SBP in patients of cirrhosis
with ascites,to ﬁnd out relative frequency of variants of ascitic ﬂuid
infection, to study clinical presentation and laboratory proﬁle and
to determine relationship between MELD score and the occurrence
of SBP.
Methods&Materials: This hospital based cross-sectional study
was carried out in a tertiary care hospital in Nagpur after taking
approval from Institute’s Ethics Committee. 100 patients of cirrho-
sis with ascites irrespective of age and gender were enrolled after
taking their written informed consent.. 20 ml of ascitic ﬂuid was
aspirated in heparinised disposable syringe; out of it 10 ml was
immediately inoculated into blood culture bottle at bedside and
sent for bacterial culture alongwith the remaining10ml for routine
biochemical and cytological examination.
Results: Majority of the patients were between 40-49 years of
age, mean age of patients diagnosed as SBP was 42.51 years. Out
of total 42 cases of SBP, classical SBP was present in 16(38.09%),
Culture negative neutrocytic ascites in 14 (33.33%) , Bacterascites
in 12 (28.57%) patients with SBP. Escherichia.coli was the most fre-
quently cultured organism isolated in 15 cases (53.570%), followed
by pseudomonas in 9 (32.14%), Klebsiella pnuemoniae in 3(10.71%)
cases . The common mode of presentation of SBP was abdominal
tenderness(65.38%) followed by hepatic encephalopathy(58.82%)
associated with abdominal pain(50%) and fever (46.66%) , dis-
tention of abdomen (44.30%) hematemesis and malena(45%).
Hyponatremiawith a serumwas found to be associatedwith severe
complications. In (52.63%) patients of SBP ascitic ﬂuid protein was
less than 1 mg/dl . MELD score was found to be a reliable index of
disease severity .
Conclusion: SBP is a fatal complication of cirrhosis with ascites.
It has heterogenous clinical presentation. Ascitic ﬂuid should be
analysed routinely in all cases of cirrhosis with ascites for the early
detection of SBP.
http://dx.doi.org/10.1016/j.ijid.2016.02.346
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Background: A classical tropical disease, Pyomyositis is a
primary suppurative bacterial infection involving the skeletal
muscles due to hematological spread, presenting with pain and
inﬂammation in the involved muscles. Incidence is more in an
immunocompromised host, with trauma, injection drug use being
common predispositions. Staphylococcus aureus is the common
inciting agent. This study was undertaken to characterise the clini-
cal proﬁle and outcomes of the disease due to a dearth of data from
India.
Methods & Materials: Methods - Retrospective study was con-
ducted on 66 patients admitted with the diagnosis of primary
pyomyositis between January 2013 to January 2015.
Inclusion criteria - Patients with pyomyositis.
Exclusion criteria - Secondary infection, concomitant febrile ill-
nesses, viral myositis
Primary outcome - Response to antibiotic or surgical therapy,
relapse or death.
Statistical analysis - Using SPSS 21. Normally data is presented
as mean ± standard deviation.
Results: Themean agewas 37.61±22.25 yrs. Amongpresenting
features, myalgia was in 98.5% patients, fever in 78.8% patients.
54.5% manifested local signs of inﬂammation and tenderness was
in 90.9% patients.
With24.2%of patients havinguncontrolled sugars, Diabeteswas
the most common risk factor. Trauma was present in 18.2% and 3%
were on steroids.
Iliopsoas was involved in 59.1% patients, Quadriceps in 13.6%
patients, Hamstrings in 7.5%. Single muscle was involved in 86.4%
of the patients and multifocal involvement in 13.6% of patients.
For diagnosis, Ultrasound was used in 56.01% of the patients,
Magnetic resonance in 30.03% and Computed tomography in
13.06% of the patients.
10.6% had Acute Kidney Injury.
Microbiologically, 18.2% patients had Methicillin sensitive
Staphylococcus aureus positivity in the culture. 12.1% patients had
Methicillin resistant Staphylococcus aureus.
81.8% of the patients recovered with antibiotics and pus
drainage. 6.1% had relapse. 3% of the patients died with sepsis.
Conclusion: Pyomyositis should be considered in the dif-
ferential in case of a painful swelling in a muscle in an
immunocompromised.
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Ultrasound should be used as an adjunct in the diagnosis.
Empiric therapy covering Staphylococcus aureus is prudent
pending culture reports.
http://dx.doi.org/10.1016/j.ijid.2016.02.347
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Virulence gene proﬁle and SCCmec types of
clinical MRSA isolates: Is there a ﬁtness cost
involved?
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Background: The success ofmethicillin resistant Staphylococcus
aureus as a pathogen is attributed to its extraordinary repertoire of
virulence factors. BasedonSCCmec types,MRSA isolates canbeclas-
siﬁed as hospital (HA-MRSA) or community acquired (CA-MRSA).
Association of certain virulence geneswith particular SCCmec types
has been previously reported. For instance, pvl gene is associated
with SCCmec types IV or V (CA- MRSA types).
Methods & Materials: Two hundred non-repetitive isolates of
MRSA from clinical specimens were screened for virulence genes
such as pvl, tsst, hlg, enterotoxin A (sea), exfoliative toxin A (eta),
intercellular adhesion (ica) genes by PCR. SCCmec typing was car-
ried out by multiplex PCR. An attempt was made to ﬁnd the
association between virulence genes and the clinical presentation
aswell as with the SCCmec types to establish the ﬁtness cost, if any.
Results: A total of 192 isolates (96%) carried one or more viru-
lence genes while 8 (4%) had none. The commonest virulence gene
encountered was ica (90%) followed by hlg (83%), sea (78%), pvl
(53%), eta (12%) and tsst (2%). Out of 200 MRSA isolates, only 40%
carried single SCCmec type, whereas 59% carried multiple SCCmec
types including a combination of classical HA and CA types. The
predominant SCCmec type found in our study was III followed by
SCCmec V. eta and pvl toxins were mainly encountered in isolates
from severe skin and soft tissue infections whereas the isolates
which were negative for the virulence genes tested were obtained
from mild skin infections. Notably, all the blood isolates (n=12)
were negative for pvl and eta, whereas all were positive for hlg.
pvl gene positivity was signiﬁcantly associated with SCCmec type
V followed by type III. Majority of the blood isolates and all the tsst
positive MRSA isolates carried SCCmec III. The single isolate with
SCCmec type II was negative for all the virulence genes tested.
Conclusion: This study documented the presence of virulence
genes in various combinations in majority of the clinical MRSA iso-
lates. No strong evidence for ﬁtness cost of SCCmecwas established
as the isolates negative for virulence genes belonged to diverse
SCCmec types.
http://dx.doi.org/10.1016/j.ijid.2016.02.348
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Background: The explosion of interest in the human micro-
biome research was sparked in part by two research initiatives
launched in 2008, the European and Chinese-led Metagenomics
of the Human Intestinal Tract Consortium and the National Insti-
tutes of Health (NIH)-sponsored Human Microbiome Project. The
new knowledge provided by these initiatives and others world-
wide are transforming our understanding of the pathogenesis of
several diseases, including asthma, inﬂammatory bowel diseases,
obesity and Type 1 diabetes, as well as the development of the
immune response linked to some vaccines. However, African popu-
lations areunderstudied in these initiatives, and there is no “African
Microbiome Initiative”. This systematic review aimed to summa-
rize and discuss the state of research on the human microbiome
in Africa, including the therapeutic role of the microbiome for the
management of certain local diseases.
Methods&Materials: Using predeﬁnedkeywords,we searched
in six electronic databases for human microbiome studies con-
ducted in Africa. In addition, to ﬁnd additional articles, we checked
references cited in eligible studies. Two authors independently
selected eligible studies published until 30 September 2015.
Results: Eighty-nine human microbiome papers were identi-
ﬁed from six electronic databases and other sources. Therewere 80
primarymicrobiomestudies (includingKhoi San (n=1) andHunter-
Gatherers (n= 4)) and 9 nested microbiome studies within existing
cohorts. 16S rRNA gene sequencingwas the techniquemostwidely
used to characterize the microbiota. The main body sites studied
were the gut (46%), vagina (25%) and the oral cavity (11%). The dis-
eases targetedweremalnutrition (n= 4), HIV/AIDS (n= 7), diarrhoea
(n= 4), and periodontitis (n= 5). These microbiome studies were
performed in individuals of all ages, with most of the studies being
conducted in adults. Kenya, Uganda, South Africa and Nigeria were
the sites of the majority of studies; however the principal investi-
gators of most of the studies (87%) were from developed countries.
TheUSANIHwas themain fundingsource (25%), followedby theBill
and Melinda Gates Foundation (9%) and the European Commision
(8%).
Conclusion: More studies of the microbiome including African
participants, focusing on endemic diseases and led by African
researchers are needed.
http://dx.doi.org/10.1016/j.ijid.2016.02.349
